TriSalus Life Sciences: CEO buys, director joins — score 43/100
TriSalus's CEO accounted for most of this cluster, with one director alongside her.
TriSalus Life SciencesInsider buyConviction 43/100
In this brief: 2 sections 1 min read
Szela Mary T (CEO and President) — 65,192 shares @ $2.4574, $160,205.36, +6.1%
Gordon Gary B. (Director) — 10,000 shares @ $2.20, $22,000, +13.8%
Seniority is maximal at 15 because the CEO bought. Size scored 11.6 of 35 on a $182,205.36 total, nearly all of it hers. Position growth contributed 1.2 of 20: a 6.1% increase on an already sizeable holding. Breadth is 15 of 30. No penalties.